SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Machaon who wrote (28529)3/15/1999 2:56:00 PM
From: Machaon  Read Replies (1) | Respond to of 32384
 
It's interesting re-reading medsunman's report from the H&Q conference in January (Posts #27371 and #27375), where he reported that Robinson had said that the Lilly/Ligand diabetes program would probably not be taking Targretin forward.